المؤلفون: Lorente E; Unidad de Presentación y Regulación Inmunes, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain., Martín-Galiano AJ; Unidad de Infecciones Intrahospitalarias, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain., Kadosh DM; Department of Biology, Technion-Israel Institute of Technology, 32000 Haifa, Israel., Barriga A; Unidad de Presentación y Regulación Inmunes, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain., García-Arriaza J; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), 28049 Madrid, Spain., Mir C; Unidad de Presentación y Regulación Inmunes, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain., Esteban M; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), 28049 Madrid, Spain., Admon A; Department of Biology, Technion-Israel Institute of Technology, 32000 Haifa, Israel., López D; Unidad de Presentación y Regulación Inmunes, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.

المصدر: Journal of proteome research [J Proteome Res] 2022 Jan 07; Vol. 21 (1), pp. 164-171. Date of Electronic Publication: 2021 Dec 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101128775 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-3907 (Electronic) Linking ISSN: 15353893 NLM ISO Abbreviation: J Proteome Res Subsets: MEDLINE

مواضيع طبية MeSH: HLA Antigens*/genetics , HLA Antigens*/metabolism , HLA-DR Antigens*, CD4-Positive T-Lymphocytes ; Humans ; Hydrophobic and Hydrophilic Interactions ; Isoelectric Point ; Parents

المؤلفون: Shraibman B; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel., Barnea E; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel., Kadosh DM; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel., Haimovich Y; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel., Slobodin G; §Rheumatology Unit, Bnai Zion Medical Center, Haifa 31048, Israel., Rosner I; §Rheumatology Unit, Bnai Zion Medical Center, Haifa 31048, Israel., López-Larrea C; ¶Hospital Universitario Central de Asturias, 33011 Oviedo, Asturias, Spain., Hilf N; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Kuttruff S; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Song C; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Britten C; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany.; ¶¶¶Association for Cancer Immunotherapy (CIMT), Langenbeckstr. 1,55131 Mainz, Germany., Castle J; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Kreiter S; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Frenzel K; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Tatagiba M; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany., Tabatabai G; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany., Dietrich PY; §§Université de Genève, Rue Gabrielle Perret Gentil 4; 1211 Geneve 14, Switzerland., Dutoit V; §§Université de Genève, Rue Gabrielle Perret Gentil 4; 1211 Geneve 14, Switzerland., Wick W; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., Platten M; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., Winkler F; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., von Deimling A; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., Kroep J; ‖‖Leiden University Medical Center, Department of Medical Oncology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Sahuquillo J; ‡‡‡Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain., Martinez-Ricarte F; ‡‡‡Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain., Rodon J; ‡‡‡Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain., Lassen U; ‖‖‖Region Hovedstaden (Center for Cancer Immune Therapy (CCIT), Herlev Hospital, Herlev Ringvej 75, DK-2730, Copenhagen, Denmark., Ottensmeier C; §§§Cancer Sciences Division, Faculty of Medicine, University of Southampton, Southampton, UK., van der Burg SH; ‖‖Leiden University Medical Center, Department of Medical Oncology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; ¶¶¶Association for Cancer Immunotherapy (CIMT), Langenbeckstr. 1,55131 Mainz, Germany., Thor Straten P; ‖‖‖Region Hovedstaden (Center for Cancer Immune Therapy (CCIT), Herlev Hospital, Herlev Ringvej 75, DK-2730, Copenhagen, Denmark., Poulsen HS; ‡‡‡‡Rigshospitalet, Departments of Radiation Biology and Oncology, Rigshospitalet 9, Blegdamsvej, DK-2100, Copenhagen, Denmark., Ponsati B; §§§§BCN Peptides, Pol. Ind. Els Vinyets-Els Fogars II. 08777 Sant Quinti de Mediona (Barcelona), Spain., Okada H; ¶¶¶¶University of California and the Parker Institute for Cancer Immunotherapy, San Francisco, CA 94131., Rammensee HG; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany., Sahin U; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Singh H; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Admon A; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel; admon@technion.ac.il.

المصدر: Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2019 Jun; Vol. 18 (6), pp. 1255-1268.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 101125647 Publication Model: Print Cited Medium: Internet ISSN: 1535-9484 (Electronic) Linking ISSN: 15359476 NLM ISO Abbreviation: Mol Cell Proteomics Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Neoplasm/*blood , Brain Neoplasms/*blood , Glioblastoma/*blood , Histocompatibility Antigens Class I/*blood , Peptides/*blood , Proteome/*metabolism, Alleles ; Biomarkers, Tumor/blood ; Brain Neoplasms/surgery ; Glioblastoma/surgery ; Humans

المؤلفون: Shraibman B, Barnea E, Kadosh DM, Haimovich Y, Slobodin G, Rosner I, López-Larrea C, Hilf N, Kuttruff S, Song C, Britten C, Castle J, Kreiter S, Frenzel K, Tatagiba M, Tabatabai G, Dietrich PY, Dutoit V, Wick W, Platten M, Winkler F, von Deimling A, Kroep J, Sahuquillo J, Martinez-Ricarte F, Rodon J, Lassen U, Ottensmeier C, van der Burg SH, Thor Straten P, Poulsen HS, Ponsati B, Okada H, Rammensee HG, Sahin U, Singh H, Admon A

المصدر: Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2019 Jun; Vol. 18 (6), pp. 1270.

نوع المنشور: Journal Article; Retraction of Publication

بيانات الدورية: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 101125647 Publication Model: Print Cited Medium: Internet ISSN: 1535-9484 (Electronic) Linking ISSN: 15359476 NLM ISO Abbreviation: Mol Cell Proteomics Subsets: PubMed not MEDLINE

المؤلفون: Shraibman B; From the ‡Biology, Technion - Israel Institute of Technology, Haifa 32000, Israel., Barnea E; From the ‡Biology, Technion - Israel Institute of Technology, Haifa 32000, Israel., Kadosh DM; From the ‡Biology, Technion - Israel Institute of Technology, Haifa 32000, Israel., Haimovich Y; From the ‡Biology, Technion - Israel Institute of Technology, Haifa 32000, Israel., Slobodin G; §Rheumatology Unit Bnai Zion Medical Center, Haifa 31048, Israel., Rosner I; §Rheumatology Unit Bnai Zion Medical Center, Haifa 31048, Israel., López-Larrea C; ¶Hospital Universitario Central de Asturias, 33011 Oviedo, Asturias, Spain., Hilf N; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Kuttruff S; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Song C; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Britten C; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany.; ¶¶¶Association for Cancer Immunotherapy (CIMT), Langenbeckstr. 1,55131 Mainz, Germany., Castle J; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Kreiter S; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Frenzel K; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Tatagiba M; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany., Tabatabai G; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany., Dietrich PY; §§Université de Genève, Rue Gabrielle Perret Gentil 4; 1211 Geneve 14, Switzerland., Dutoit V; §§Université de Genève, Rue Gabrielle Perret Gentil 4; 1211 Geneve 14, Switzerland., Wick W; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., Platten M; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., Winkler F; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., von Deimling A; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., Kroep J; ‖‖Leiden University Medical Center, Department of Medical Oncology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Sahuquillo J; **Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain., Martinez-Ricarte F; **Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain., Rodon J; **Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain., Lassen U; ‡‡‡Region Hovedstaden (Center for Cancer Immune Therapy (CCIT), Herlev Hospital, Herlev Ringvej 75, DK-2730, Copenhagen, Denmark., Ottensmeier C; §§§Cancer Sciences Division, Faculty of Medicine, University of Southampton, Southampton, UK., van der Burg SH; ‖‖Leiden University Medical Center, Department of Medical Oncology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; ¶¶¶Association for Cancer Immunotherapy (CIMT), Langenbeckstr. 1,55131 Mainz, Germany., Thor Straten P; ‡‡‡Region Hovedstaden (Center for Cancer Immune Therapy (CCIT), Herlev Hospital, Herlev Ringvej 75, DK-2730, Copenhagen, Denmark., Poulsen HS; ‖‖‖Rigshospitalet, Departments of Radiation Biology and Oncology, Rigshospitalet 9, Blegdamsvej, DK-2100, Copenhagen, Denmark., Ponsati B; ***BCN Peptides, Pol. Ind. Els Vinyets-Els Fogars II. 08777 Sant Quinti de Mediona (Barcelona), Spain., Okada H; ‡‡‡‡University of California, San Francisco, CA 94131 USA., Rammensee HG; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany., Sahin U; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Singh H; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Admon A; From the ‡Biology, Technion - Israel Institute of Technology, Haifa 32000, Israel; admon@technion.ac.il.

المصدر: Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2018 Nov; Vol. 17 (11), pp. 2132-2145. Date of Electronic Publication: 2018 Aug 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication

بيانات الدورية: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 101125647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-9484 (Electronic) Linking ISSN: 15359476 NLM ISO Abbreviation: Mol Cell Proteomics Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Neoplasm/*blood , Glioblastoma/*blood , HLA Antigens/*metabolism , Peptides/*metabolism , Proteome/*metabolism, Alleles ; Amino Acid Sequence ; Antigens, Neoplasm/metabolism ; Biomarkers, Tumor/blood ; Cell Membrane/metabolism ; Glioblastoma/surgery ; Humans ; Peptides/blood ; Peptides/chemistry ; Solubility

المؤلفون: Komov L; Department of Biology, Technion-Israel Institute of Technology, Haifa, 32000, Israel., Kadosh DM; Department of Biology, Technion-Israel Institute of Technology, Haifa, 32000, Israel., Barnea E; Department of Biology, Technion-Israel Institute of Technology, Haifa, 32000, Israel., Milner E; Department of Biology, Technion-Israel Institute of Technology, Haifa, 32000, Israel., Hendler A; Department of Biology, Technion-Israel Institute of Technology, Haifa, 32000, Israel., Admon A; Department of Biology, Technion-Israel Institute of Technology, Haifa, 32000, Israel.

المصدر: Proteomics [Proteomics] 2018 Jun; Vol. 18 (12), pp. e1700248. Date of Electronic Publication: 2018 Jun 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101092707 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1615-9861 (Electronic) Linking ISSN: 16159853 NLM ISO Abbreviation: Proteomics

مواضيع طبية MeSH: Antigen Presentation/*immunology , Breast Neoplasms/*metabolism , Cell Membrane/*metabolism , Histocompatibility Antigens Class I/*metabolism , Peptide Fragments/*metabolism, Breast Neoplasms/immunology ; Breast Neoplasms/pathology ; Cell Proliferation ; Female ; Histocompatibility Antigens Class I/immunology ; Humans ; Ligands ; MCF-7 Cells ; Peptide Fragments/immunology ; Protein Binding

المؤلفون: Shraibman B; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa, Israel., Kadosh DM; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa, Israel., Barnea E; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa, Israel., Admon A; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa, Israel admon@tx.technion.ac.il.

المصدر: Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2016 Sep; Vol. 15 (9), pp. 3058-70. Date of Electronic Publication: 2016 Jul 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 101125647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-9484 (Electronic) Linking ISSN: 15359476 NLM ISO Abbreviation: Mol Cell Proteomics Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Neoplasm/*chemistry , Azacitidine/*analogs & derivatives , Brain Neoplasms/*immunology , Glioblastoma/*immunology , HLA Antigens/*chemistry , Peptides/*isolation & purification, Azacitidine/pharmacology ; Brain Neoplasms/drug therapy ; Cell Line, Tumor ; DNA Methylation/drug effects ; Decitabine ; Gene Expression Profiling/methods ; Gene Expression Regulation, Neoplastic/drug effects ; Glioblastoma/drug therapy ; Humans ; Immunotherapy ; Proteomics/methods ; Sequence Analysis, RNA